Recombinant NV-A01 adenovirus injection
2023IIT003
Phase 1 small_molecule active
Quick answer
Recombinant NV-A01 adenovirus injection for Advanced Glioblastoma Patients is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Advanced Glioblastoma Patients
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active